2m 2m 2m 2m 2m 2m 2m
- $16,324.00Market Cap
- 0.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Nutranomics (NNRX)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 26
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer's blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing System that improves the absorption of nutrients. In addition, it offers educational services, including various types of analyses, trainings, certifications, and group presentations to individuals and industry professionals. The company distributes its products through sales representatives throughout North America and Asia, as well as through retail stores. Nutranomics, Inc. has a strategic partnership with Terra-Formance, LLC. The company was founded in 1995 and is headquartered in Salt Lake City, Utah.
Key Executives
- Neil Zoller
- Laura Riffel
- Jonathan Bishop
- Geoffrey Bazegian
Current Ownership Distribution
- Other16.3B (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)